1.Research progress of Pinellia ternata and its active ingredients in car-diovascular diseases
Min SONG ; Tingting DIAO ; Yichao WANG ; Luyi LIU ; Qiqi QI ; Jingjing BI ; Nailiang ZHU ; Xinrong QIAO
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(2):251-264
Cardiovascular diseases(CVD)are chronic disease with high morbidity and mortality in the world.Pinellia ternatais a traditional Chi-nese medicinal herb and has the effects on drying dampness,resolving phlegm,lowering symptoms,stopping vomiting and relieving swelling.In recent years,researches showed that Pinellia ternataand its active ingredients(β-sitosterol,baicalin,baica-lein,quercetin)had significant effects in the treat-ment of cardiovascular diseases.This review sum-marized and analyzed the role and mechanism of Pinellia ternata and its active ingredients in cardio-vascular diseases,which provided a theoretical ba-sis for its clinical application.
2.Research progress of Pinellia ternata and its active ingredients in car-diovascular diseases
Min SONG ; Tingting DIAO ; Yichao WANG ; Luyi LIU ; Qiqi QI ; Jingjing BI ; Nailiang ZHU ; Xinrong QIAO
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(2):251-264
Cardiovascular diseases(CVD)are chronic disease with high morbidity and mortality in the world.Pinellia ternatais a traditional Chi-nese medicinal herb and has the effects on drying dampness,resolving phlegm,lowering symptoms,stopping vomiting and relieving swelling.In recent years,researches showed that Pinellia ternataand its active ingredients(β-sitosterol,baicalin,baica-lein,quercetin)had significant effects in the treat-ment of cardiovascular diseases.This review sum-marized and analyzed the role and mechanism of Pinellia ternata and its active ingredients in cardio-vascular diseases,which provided a theoretical ba-sis for its clinical application.
3.OBSERVATION OF CURATIVE EFFECT OF HA IN 23 CASES WITH CML
Yichao QIAO ; Yinxia CHEN ; Goudong TIAN
Journal of Xi'an Jiaotong University(Medical Sciences) 1981;0(02):-
The 23 cases with chronic myelogenousleukemia (CML) were treated with program ofharringtonine and ara-c (HA) and the results werethat the 13 cases got complete remission and 10cases got partial remission. Comparing with thecontrol group the patients of which were treatedwith busulfan, the authors found that the spendedtime of decreased WBC in blood (WBC decreasedto 10. 0 ? 10~9/L) and reduced spleen (reduced tosmallest status of spleen) and improvement of self-sensation symptoms in the group treated with HAwere better than those in control group. The HAprogram for cases who recured CML again and re-ceived maintenance cure after remission of CMLwas still effective. The time of maintenance cureand interval should be individualized.

Result Analysis
Print
Save
E-mail